Source: http://health.yahoo.net/news/s/nm/gsk-says-new-data-support-filing-of-diabetes-drug
Tuesday, 3 April 2012
GSK says new data support filing of diabetes drug
LONDON (Reuters) - GlaxoSmithKline will push ahead with plans to file its experimental once-weekly diabetes drug albiglutide for regulatory approval, following the read-out from a series of clinical trials. Albiglutide belongs to the same class of...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.